insider ownership at 60%
Dual-action CB-101 for eczema patients
FDA-cleared Photocil addressing psoriasis and vitiligo
Revenue-generating Hair Enzyme Booster
Letter of Intent signed to acquire NOVODX and GoldN
Five new product launches expected by 2025
Nasdaq uplisting targeted